STIFEL FINANCIAL CORP - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 233 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.

Quarter-by-quarter ownership
STIFEL FINANCIAL CORP ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,602,955
+25.5%
58,835
+2.5%
0.00%0.0%
Q2 2023$1,277,524
+6.8%
57,413
+4.0%
0.00%0.0%
Q1 2023$1,195,926
+69.7%
55,213
+59.1%
0.00%
+100.0%
Q4 2022$704,727
-4.9%
34,698
+20.0%
0.00%0.0%
Q3 2022$741,000
+20.1%
28,906
+11.4%
0.00%0.0%
Q2 2022$617,000
+17.1%
25,948
+10.9%
0.00%0.0%
Q1 2022$527,000
+25.8%
23,388
+10.6%
0.00%0.0%
Q4 2021$419,000
+38.7%
21,156
+37.9%
0.00%
Q3 2021$302,000
+33.6%
15,346
+49.4%
0.00%
Q2 2021$226,000
-92.7%
10,273
-91.4%
0.00%
-100.0%
Q4 2020$3,116,000
-17.8%
119,089
-45.3%
0.01%
-25.0%
Q3 2020$3,790,000
-1.4%
217,814
-4.7%
0.01%
-11.1%
Q2 2020$3,845,000
+36.5%
228,567
-4.3%
0.01%
+12.5%
Q1 2020$2,816,000
-15.3%
238,815
+0.3%
0.01%0.0%
Q3 2019$3,325,000
+9.4%
237,987
-11.1%
0.01%0.0%
Q2 2019$3,038,000
-11.5%
267,725
-7.0%
0.01%
-20.0%
Q1 2019$3,431,000
-45.4%
287,813
-38.8%
0.01%
-50.0%
Q4 2018$6,284,000
-8.3%
469,989
-3.4%
0.02%0.0%
Q3 2018$6,853,000
+3545.2%
486,285
+3908.9%
0.02%
+1900.0%
Q2 2018$188,000
+3.3%
12,130
+11.6%
0.00%0.0%
Q1 2018$182,00010,8740.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 6,911,376$155,644,0006.95%
Parallel Advisors, LLC 1,944,319$47,014,0001.86%
TANAKA CAPITAL MANAGEMENT INC 39,289$885,0001.79%
S&T BANK/PA 508,546$11,452,0001.73%
Bridge City Capital, LLC 83,967$1,891,0000.88%
Birchview Capital, LP 50,000$1,126,0000.81%
Quantedge Capital Pte Ltd 113,012$2,545,0000.75%
FAS Wealth Partners, Inc. 289,625$6,522,0000.61%
AJ WEALTH STRATEGIES, LLC 396,029$8,919,0000.44%
TRUSTCORE FINANCIAL SERVICES, LLC 208,806$4,702,0000.41%
View complete list of CORCEPT THERAPEUTICS INC shareholders